Company Filing History:
1 out of 12 
1 out of 1,345 
Years Active: 2025
Title: The Innovations of Geoffrey Parsons: A Pioneer in Cancer Treatment
Introduction: Geoffrey Parsons is an inventive mind based in Jamaica Plain, MA, whose contributions in the field of immunotherapy have the potential to significantly impact cancer treatment. With one patent to his name, Parsons has focused on creating advanced medical therapies that harness the body’s own immune system to fight disease.
Latest Patents: Geoffrey Parsons holds a patent for an isolated T cell receptor (TCR) specific for MAGE-A4. This patent outlines a polypeptide that comprises a functional portion of the TCR, as well as a multivalent TCR complex, a nucleic acid encoding the TCR, and a cell that expresses the TCR. Notably, the patent emphasizes the use of this TCR as a medicament, specifically for treating cancer, showcasing Parsons' commitment to developing targeted therapies.
Career Highlights: Throughout his career, Geoffrey Parsons has worked at leading companies in the biotechnology sector. His experience includes significant tenure at Medigene Immunotherapies GmbH and Regeneron Pharmaceuticals, Inc., where he contributed his expertise in the development of innovative immunotherapies. His dedication to advancing cancer treatments reflects his passion for utilizing scientific research to improve patient outcomes.
Collaborations: Geoffrey has collaborated with notable colleagues such as Christian Ellinger and Daniel Sommermeyer. These partnerships have fostered a creative environment contributing to the development of transformative therapies in the field of immunotherapy. Working alongside skilled professionals has enhanced Parsons' ability to innovate and bring cutting-edge solutions to medical challenges.
Conclusion: Geoffrey Parsons stands out as a remarkable inventor whose patent in T cell receptor therapy exemplifies the power of innovation in the fight against cancer. As the medical community continues to explore new frontiers in immunotherapy, the contributions of Parsons and his collaborations will undoubtedly play an essential role in shaping the future of cancer treatments.